Significance of Crypt Atypia in Barrett’s Esophagus: A Clinical, Molecular, and Outcome Study
Authors:
- 24 October 2023
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 22 (4) , 741-748.e2
Abstract
No abstract availableKeywords
Funding Information
- Prevent Cancer Foundation
- National Institutes of Health (U2CCA271972)
- National Institutes of Health (P01 CA91955)
This publication has 24 references indexed in Scilit:
- ACG Clinical Guideline: Diagnosis and Management of Barrett’s EsophagusAmerican Journal of Gastroenterology, 2016
- Impact of Endoscopic Surveillance on Mortality From Barrett's Esophagus–Associated Esophageal AdenocarcinomasGastroenterology, 2013
- Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagusGut, 2012
- The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysisGut, 2011
- Interobserver Variability in the Diagnosis of Crypt Dysplasia in Barrett EsophagusAmerican Journal of Surgical Pathology, 2011
- Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United StatesClinical Gastroenterology and Hepatology, 2009
- Metaplastic Esophageal Columnar Epithelium Without Goblet Cells Shows DNA Content Abnormalities Similar to Goblet Cell–Containing EpitheliumAmerican Journal of Gastroenterology, 2009
- Dysplasia and Cancer in a Large Multicenter Cohort of Patients With Barrett’s EsophagusClinical Gastroenterology and Hepatology, 2006
- Crypt Dysplasia With Surface MaturationAmerican Journal of Surgical Pathology, 2006
- Observer variation in the diagnosis of dysplasia in Barrett's esophagusHuman Pathology, 1988